-
C4 Therapeutics Announces Pricing of Public Offering
-
C4 Therapeutics Announces Pricing of Public Offering
-
C4 Therapeutics Inc. (CCCC) Announces Proposed Offering of 4.25M Shares
-
C4 Therapeutics Launches Proposed Public Offering
-
C4 Therapeutics Launches Proposed Public Offering
-
BMO Capital Starts C4 Therapeutics (CCCC) at Outperform
-
BMO Capital Starts C4 Therapeutics (CCCC) at Outperform
-
C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
C4 Therapeutics (CCCC) IPO Opens 40% Higher
-
C4 Therapeutics Inc. (CCCC) Prices 9.6M Share Upsized IPO at $19/Sh
-
C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering
-
C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering